Karina Arocho-Gonzalez
Hematology & Oncology · Hato Rey, PRNPI 1851724512
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,212 of the $10,674 with a category attached, or 76.9%. It is spread thinly across 39 manufacturers, the largest accounting for just 21.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $2,844 and has fallen 59.0% since, to $1,167 in 2025. That places this record below the midpoint for hematology & oncology clinicians in PR, where the typical reported total is $10,882.
Across 345 payments — averaging $30.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Beigene, Ltd.$2K
- Johnson & Johnson$1K
- E.r. Squibb & Sons, L.L.C.$678
- Genentech USA, Inc.$673
- Amgen$665
- PBG Puerto Rico LLC$655
- plus $5K from 33 others
Across 84 payments — averaging $13,385 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$909K
- Pfizer$107K
- Beone Medicines Ltd.$45K
- Janssen Research & Development, LLC$35K
- AstraZeneca$25K
- Jazz Pharmaceuticals Inc.$4K
What the payments were for
- Consulting fees$2,25021%
- Food & beverage$8,21277%
- Education$2122%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Beigene, Ltd. | 1 | $2,250 |
| Johnson & Johnson(2 entities) | 48 | $1,093 |
| E.r. Squibb & Sons, L.L.C. | 24 | $678 |
| Genentech USA, Inc. | 31 | $673 |
| Amgen | 26 | $665 |
| PBG Puerto Rico LLC | 33 | $655 |
| AstraZeneca(2 entities) | 20 | $611 |
| Merck | 24 | $519 |
| AbbVie | 20 | $463 |
| Eli Lilly Export S.A. Puerto Rico Branch | 18 | $393 |
| Novartis | 15 | $362 |
| Sanofi | 15 | $323 |
| Medtronic | 5 | $215 |
| Eisai Inc. | 6 | $211 |
| Tempus AI, Inc | 8 | $192 |
| CTI Biopharma Corp. | 1 | $145 |
| Puma Biotechnology, Inc. | 6 | $117 |
| Pfizer | 6 | $113 |
| Verity Pharmaceuticals Inc. | 5 | $109 |
| Rigel Pharmaceuticals, Inc. | 2 | $107 |
| Exelixis Inc. | 2 | $104 |
| Caris MPI, Inc. | 3 | $89 |
| Gilead(2 entities) | 2 | $62 |
| Incyte Corporation | 3 | $61 |
| Array Biopharma Inc | 2 | $50 |
| Bayer Puerto Rico Inc. | 2 | $50 |
| EMD Serono, Inc. | 2 | $40 |
| Sobi, Inc | 2 | $40 |
| Clovis Oncology, Inc. | 2 | $39 |
| Beigene USA, Inc. | 1 | $31 |
| Bristol Myers Squibb | 1 | $30 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $27 |
| GSK | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
| Springworks Therapeutics, Inc. | 1 | $22 |
| Beone Medicines USA, Inc. | 1 | $21 |
| Taiho Oncology, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,674 in reported general payments places this provider in the 45th percentile of 138 hematology & oncology providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PromactaEltrombopag Olamine | 41 | $529,592 |
| RevlimidLenalidomide | 21 | $340,678 |
| TagrissoOsimertinib Mesylate | 13 | $214,230 |
| ErleadaApalutamide | 13 | $192,962 |
| AvastinBevacizumab | 12 | $47,816 |
| Abiraterone Acetate | 17 | $30,944 |
| RetacritEpoetin Alfa-Epbx | 16 | $12,752 |
| Hydroxyurea | 40 | $1,034 |
| Anastrozole | 62 | $1,003 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 22 | $495 |
| Tamoxifen Citrate | 14 | $351 |
| Ondansetron Hcl | 21 | $293 |
| Dexamethasone | 21 | $173 |
| Prednisone | 21 | $132 |
| Pantoprazole Sodium | 12 | $124 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisPromacta | $362 | $529,59241 claims |
| Bristol Myers SquibbRevlimid | $30 | $340,67821 claims |
| AstraZenecaTagrisso | $611 | $214,23013 claims |
| Johnson & JohnsonErleada | $1,093 | $192,96213 claims |
| PfizerRetacrit | $113 | $12,75216 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 138 hematology & oncology providers in Puerto Rico.
Other hematology & oncology in Hato Rey
- Rafael BetancourtHato Rey$21K
- Alexis Cruz ChaconSan Juan$450K
- Jose Lozada CostasSan Juan$260K
- Cristian Rodriguez ArochoSan Juan$227K
- Noridza Rivera RodriguezSan Juan$177K
- Joel Lopez-FigueroaHumacao$163K
- Mirelis AcostaSan Juan$154K
- Luis Baez VallecilloSan Juan$107K
- Carlos Mendez SerranoCaguas$91K
- Santa MerleMoca$84K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.